Search for:
Category

Submenue

Category

The long-awaited implementation in statutory law of the fight against medical devices and in vitro diagnosis medical devices shortages mechanism is currently being discussed in the French Parliament, in a bill containing various provisions adapting French law to European Union law on diverse topics and particularly in the field of public health.

In recent weeks, the Decree on Electronic Export Incentives and the new Regulation on Consumer Arbitration Committees have been published in the commercial and trade sector. In addition, there have been various amendments to the communiqués on environmentally friendly design requirements and energy labeling for certain products, the Regulation on Consumer Credit Agreements, the Law on the Regulation of Retail Trade, the Regulation on the General Principles of Waste Pretreatment and Recovery Facilities and the Regulation on the Principles and Rules to be Applied in Retail Trade. In addition, the monetary limits for application to consumer courts and the fines for consumer law violations have been increased.

The Singapore Association of Pharmaceutical Industries Code of Conduct has been amended to include key principles when interacting with patients and patient organizations. The revisions are effective from 1 January 2023.
Article 11, which previously only expressly governed interactions between SAPI-represented pharmaceutical companies (Member Companies) and patient organizations, has been revised to include Member Companies’ interactions with patients. The amended Article 11.1 sets out the key principles to be adhered to when interacting with patients and patient organizations.

In the spirit of Bank Indonesia’s Payment System 2025 Visions that were introduced in May 2019, and in conjunction with the G20 Roadmap for Enhancing Cross-Border Payments, Bank Indonesia has agreed on cooperating with the Japanese Ministry of Economy, Trade and Industry to enable consumers and merchants in both countries to make and accept instant cross-border QR payments. The memorandum of understanding for this cooperation was signed on 9 December 2022 in Tokyo.

On 28 November 2022, the EU institutions formally adopted a Regulation on foreign subsidies distorting the internal market. The new rules will have a major impact on M&A transactions and will significantly increase the administrative burden facing many EU and non-EU companies doing business in Europe. The Regulation is part of a broader effort to protect the EU’s geopolitical “open strategic autonomy”. It aims to level the playing field by allowing the European Commission to intervene where foreign subsidies granted directly or indirectly by third countries threaten to distort the EU internal market.

On 10 November 2022, the National Coordination Centre for Ethics Committees published the updated versions of the ‘Contract for the performance of clinical trials on medicines’, the ‘Contract for the performance of independent clinical trials on medicines’ and the ‘Contract for the performance of clinical investigations on medical devices that are not CE marked or CE marked but used outside their intended use’.